Navigation Links
Frost & Sullivan Honours CapsoVision for CapsoCam SV-1, its Game-changing Gastrointestinal Capsule Endoscope

LONDON, March 14, 2013 /PRNewswire/ -- Based on its recent analysis of the endoscopy devices market, Frost & Sullivan recognizes CapsoVision with the 2013 European Product Differentiation Excellence Award.

CapsoVision's CapsoCam SV-1, a small bowel capsule endoscope equipped with four cameras providing a 360° panoramic view of the bowel, is set to revolutionise the gastrointestinal endoscope market. Other available capsule endoscopes only show images across a 150° field of view.

CapsoCam SV-1 records and stores the data on-board, lowering the need for external recording harnesses, which is a must-have in conventional capsule endoscopes. It uses the smart motion sense technology which allows images to be captured only during capsule motion.

"When no motion is detected during the travel, the CapsoCam SV-1 enters the monitor mode, whereby images are captured, but not stored; this serves to reduce the redundancy of the images captured," said Frost & Sullivan's Program Manager for Medical Devices, Sowmya Rajagopalan . "This monitor mode also conserves power and extends the battery life for the product."

The quality of the images and the capsule's ability to capture all abnormalities are crucial for the success of the procedure. CapsoCam SV-1 captures 20 frames per second for the first two hours at a rate of 5 frames per second per camera and thereafter, 12 frames per second at a rate of 3 frames per second per camera. Competing capsule endoscopes can capture only 2 to 3 frames per second. This increase in frequency and number of images captured, as well as wider views, offer better visualization of the abnormalities, walls of the intestines and other layers.

The product also has 16 independently-equipped light emitting diodes (LEDs) for lighting. The light intensity decreases near the lumen and increases away from the lumen, thus providing optimal lighting for the capture of top quality images.

"The CapsoCam SV-1 capsule largely plugs the gaps in the first-generation capsule endoscopes, thus increasing its clinical effectiveness," noted Rajagopalan. "Interestingly, the product is also more affordable than conventional capsule endoscopes, which enhances its adoption prospects in the current straitened circumstances."

Each year, Frost & Sullivan presents this award to the company that has demonstrated superior features and functionality as well as quality and complexity. CapsoVision has also exhibited high levels of customization, excellent product mix, and met the requirements of its target market.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis and extensive secondary research to identify best practices in the industry.

About CapsoVision

CapsoVision, Inc. is a Silicon Valley, CA based medical device innovator.  The company is emerging as a strong value creator in GI medical devices, with a mission to empower physicians and patients with innovations. CapsoVision is currently working in 50+ countries through strong distribution partners.

The innovative new technologies embedded in CapsoCam SV-1 aims to empower gastroenterologists and their teams to achieve significantly better clinical outcomes and improving theirs and their patient's Quality of Life and at the same time providing economical and affordable solutions.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on "the next big thing"

Register:         Gain access to visionary innovation


Srini Muthuswamy
CapsoVision, Inc.
T: +1 408 6219605

Kristina Menzefricke
Best Practices Group
Frost & Sullivan
T: +44 (0) 207 9157862

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Researchers Expect a Marginal Increase in Laboratory Product Budgets for 2013, Finds Frost & Sullivan
2. Bio-Rad Receives the 2012 Frost & Sullivan North America Laboratory Researchers Choice Award for Future Market Leader
3. Frost & Sullivan Recognizes Cytomedix for its Pioneering System that Supports the Emerging Regenerative Therapies Market
4. Frost & Sullivan: Government Support Vital to Encourage Venture Capital Investments in the North American Healthcare Industry
5. Product Differentiation to Boost European Human Growth Hormones Market, Says Frost & Sullivan
6. Frost & Sullivan Recognizes KAERs Game-Changing Innovating Aerosol Drug Delivery Methods for High-Dose Respiratory Disease Therapeutics
7. Frost & Sullivan Recognizes GenePOCs Growth Backed by Strong Leadership and Technology Excellence
8. Frost & Sullivan Accolade for Swissrays Exceptional Dedication to its Customers
9. Novel Biomaterials Accelerate the Development of Innovative Wound Care Management Technologies, Finds Frost & Sullivan
10. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
11. Frost & Sullivan Acknowledges that PKCs Biosensors are Expected to Become the New Industry Standard in Pathogen Testing
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015 USP 800 applies ... preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, physician ... The chapter also covers all entities which store, ... hospitals, other healthcare institutions, patient treatment clinics, physicians, ... --> --> What is the ...
(Date:11/25/2015)... Nov. 25, 2015  Mindray Medical ... MR ), a leading developer, ... worldwide, today announced that it will ... of shareholders at the Company,s Hong Kong office ... Prince Edward West Road, Mongkok KL, Hong ...
(Date:11/25/2015)... 2015 Research and Markets ( ) ... - Global Forecast to 2020" report to their ... for 37.21% of the total market share in 2014. ... region is projected to growth at the highest CAGR ... primarily to the fast growing water, industrial gas treatment, ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
(Date:11/24/2015)... ... ... DMG Productions announced that they will feature Aphria, Inc., in an upcoming episode ... and show times TBA. , Aphria, Inc., is a publicly traded company incorporated under ... medical marijuana pursuant to the Marijuana for Medical Purposes Regulations (the “MMPR”). , Aphria ...
(Date:11/24/2015)... ... ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, Dec. ... has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls under ... the device regulations. , Come up short in an inspection and the FDA can ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... organization will waive paid entry and parking fees at several of their most ... Mountain in Great Barrington in support of REI’s Black Friday #OptOutside Campaign. The ...
Breaking Medicine News(10 mins):